MoonLake Immunotherapeutics Statistics
NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.07+0.04 (+0.36%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MoonLake Immunotherapeutics by the numbers
MoonLake Immunotherapeutics has a market capitalization of $942.1 million based on 85.11M shares outstanding. With trailing EPS of $-3.66, MoonLake Immunotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.7% below its 50-day average and 31.5% below its 200-day average.
Average daily trading volume is 1.64M shares, or about $18.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MLTX valuation vs. peer median
| Metric | MLTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $942.13M | $952.36M | -1% |
| Avg. volume | 1.64M | 511.69K | +221% |
Peer median across 8 companies: SVRA, CYRX, SPTX, AKTS, OMER, LTGO, ANRO, MTRI.
Valuation
- Market cap
- $942.13M
- EPS (TTM)
- $-3.66
- Shares outstanding
- 85.11M
Price and trading
- Previous close
- 11.03
- Open
- 10.79
- Day range
- 10.73 – 11.30
- 52-week range
- 9.46 – 23.29
- 52-week change
- -12.63%
- Beta
- —
- Volume
- 1.72M
- Average volume
- 1.64M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 942.13M
- Forward Pe
- -3.26
- Eps
- -3.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.29
- Week52 Low
- 9.46
- Avg Volume
- 1.64M
- Shares Outstanding
- 85.11M
- Ma50
- 11.61
- Ma200
- 16.16
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -52.47%
- Pct From52w Low
- 17.02%